Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
Marty
M
M
Lepage
E
E
Guy
H
H
Bordessoule
D
D
Desablens
B
B
Harousseau
J L
JL
Guilhot
F
F
Leverger
G
G
Schaison
G
G
Boiron
M
M
D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005602:France; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011897:Random Allocation; D012074:Remission Induction; D013997:Time Factors
D000677:Amsacrine; D003561:Cytarabine; D003520:Cyclophosphamide; C002205:zorubicin; D003630:Daunorubicin